mob

Search This Blog

468x60

728

728x90

468,

250

250+300onk

Background: Pulmonary embolism (PE) in children carries a significant morbidity and mortality. We examined previously described factors in

 


Abstract

Background: Pulmonary embolism (PE) in children carries a significant morbidity and mortality. We examined previously described factors in 2 cohorts of children tested for PE and identified novel factors.

Methods: We combined data from 2 retrospective cohorts. Patients up to age 21 years were included who underwent imaging or D-dimer testing for PE, with positive radiologic testing being the gold standard. Combined predictor variables were examined by univariate analysis and then forward stepwise multivariable logistic regression.

Results: The combined data set yielded 1103 patients with 42 unique predictor variables, and 93 PE-positive patients (8.4%), with a median age of 16 years. Univariate analysis retained 17 variables, and multivariable logistic regression found 9 significant variables with increased probability of PE diagnosis: age-adjusted tachycardia, tachypnea, hypoxia, unilateral limb swelling, trauma/surgery requiring hospitalization in previous 4 weeks, prior thromboembolism, cancer, anemia, and leukocytosis.

Conclusion: This combined data set of children with suspected PE discovered factors that may contribute to a diagnosis of PE: hypoxia, unilateral limb swelling, trauma/surgery requiring hospitalization in previous 4 weeks, prior thromboembolism, and cancer, age-adjusted tachycardia, tachypnea, anemia, and leukocytosis. Prospective testing is needed to determine which criteria should be used to initiate diagnostic testing for PE in children.

PMID: 31989094 [PubMed]

14:32

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

14:32

In reply to this message

pubmed: caandvteortroorpul

RNA expression and risk of venous thromboembolism in lung cancer.


Related Articles

RNA expression and risk of venous thromboembolism in lung cancer.


Res Pract Thromb Haemost. 2020 Jan;4(1):117-123


Authors: Sussman TA, Abazeed ME, McCrae KR, Khorana AA


No comments:

Post a Comment

اكتب تعليق حول الموضوع

ACERUMEN، زجاجة جرعة واحدة

  جديد   عرض تقديمي 10 زجاجات الموزع أو الشركة المصنعة زينيث فارما تعبير عوامل التوتر السطحي الخفيفة (أسيل ساركوزينات الصوديوم وإستر السكروز...

Search This Blog